Tuberculosis treatment success rate (% of new cases) in Norway
Norway: Tuberculosis treatment success rate (% of new cases) was 83.0% in 2023. ▬ Flat
Tuberculosis treatment success rate in Norway, 2000–2023
Source: Global Tuberculosis Report, World Health Organization (WHO). Measured in % of new cases.
Analysis
Norway recorded 83.0% for tuberculosis treatment success rate in 2023.
The figure is up 1.2% on the previous year and down 6.7% over ten years.
Over the whole period, tuberculosis treatment success rate in Norway peaked at 97.0% in 2003 and was at its lowest, 70.0%, in 2000.
Norway ranks 110th of 203 countries on this measure, in the middle of the range.
Tuberculosis treatment success rate (% of new cases) in Norway, year by year
| Year | % of new cases | Change |
|---|---|---|
| 2000 | 70.0% | — |
| 2001 | 87.0% | +24.3% |
| 2002 | 80.0% | -8.0% |
| 2003 | 97.0% | +21.2% |
| 2004 | 88.0% | -9.3% |
| 2005 | 91.0% | +3.4% |
| 2006 | 88.0% | -3.3% |
| 2007 | 71.0% | -19.3% |
| 2008 | 87.0% | +22.5% |
| 2009 | 86.0% | -1.1% |
| 2010 | 89.0% | +3.5% |
| 2011 | 88.0% | -1.1% |
| 2012 | 79.0% | -10.2% |
| 2013 | 89.0% | +12.7% |
| 2014 | 84.0% | -5.6% |
| 2015 | 88.0% | +4.8% |
| 2016 | 88.0% | +0.0% |
| 2017 | 91.0% | +3.4% |
| 2018 | 84.0% | -7.7% |
| 2019 | 85.0% | +1.2% |
| 2020 | 89.0% | +4.7% |
| 2021 | 87.0% | -2.2% |
| 2022 | 82.0% | -5.7% |
| 2023 | 83.0% | +1.2% |
Norway compared with similar countries
- Norway's 83.0% is above the median for high income countries, which is 76.0%, 1.1× the median. (73 countries reporting)
- Norway's 83.0% is above the median for Europe & Central Asia, which is 77.0%, 1.1× the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.5% | 70.0% | 97.0% | 10 |
| 2010s | 86.5% | 79.0% | 91.0% | 10 |
| 2020s | 85.2% | 82.0% | 89.0% | 4 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Un projection of annual infant deaths 12 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.217 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0238 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0617 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0251 units per person (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Norway?
- Tuberculosis treatment success rate in Norway was 83.0% in 2023, according to Global Tuberculosis Report, World Health Organization (WHO).
- What is the highest tuberculosis treatment success rate recorded in Norway?
- The highest recorded value was 97.0% in 2003.
- What is the lowest tuberculosis treatment success rate recorded in Norway?
- The lowest recorded value was 70.0% in 2000.
- How does Norway rank for tuberculosis treatment success rate?
- Norway ranks 110th out of 203 countries with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Norway?
- Over the last ten years it is down 6.7%. The long-run trend across the full record is flat.
- Where does this Norway data come from?
- The figures come from Global Tuberculosis Report, World Health Organization (WHO), published as part of Tuberculosis treatment success rate (% of new cases). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).